News

The company has reported net sales of CHF45.61 billion in 2008, a decrease of 1%, compared to CHF46.13 billion posted in 2007. Operating profit was CHF13.92 billion, a

In this role, Dr Duddu will lead all aspects of the Cephalon drug delivery business at Cima, the company’s wholly owned drug delivery subsidiary located in suburban Minnesota.

Prior to joining Bilcare Global Clinical Supplies (GCS), Mr Moult worked as senior director of clinical trial supplies for UCB (Belgium) where he was also integral to technical

“Our 2008 accomplishments were marked by substantial progress across our product pipeline, in particular by successfully demonstrating the therapeutic potential of SGN-35 and the promise of our antibody-drug

Haemonetics asserted that Fenwal’s blood collecting device infringed its patent for an automated blood collection system. The case was heard in the U.S. District Court for Massachusetts (No.

The technology provides a platform of diagnostic tests used by physicians and researchers to monitor the success of anti-HIV treatment by determining drug resistance and disease strength of

The company has said that it has begun accepting orders for the solution and has started commercial production of the solution’s components for shipment during the first quarter

Net income of $2.0 million for the fourth quarter of 2008 and $3.1 million of net income for 2008 Consolidated fourth quarter revenue of $28.2 million, up 31

The Realism study is a prospective, multi-center, continued access registry of the Everest II study. The Realism study consists of two arms: a high risk arm and a